Multicenter phase II study of rituximab-ABVD in classic Hodgkin lymphoma (cHL)

Category Primary study
JournalJournal of Clinical Oncology
Year 2011
This article has no abstract
Epistemonikos ID: 61e676b2b0aa3b8901c92d6a8205d7a843fe846a
First added on: Feb 04, 2025